Implenia AG (XSWX:IMPN) Research & Development: CHF0 Mil (TTM As of Dec. 2025)


XSWX:IMPN Implenia AG XSWX:IMPN
56 GF Score
Price CHF71.90
GF Value CHF35.34
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Implenia AG Research & Development?

Implenia AG XSWX:IMPN -3.23% 56 Research & Development is CHF0 Mil as of Dec. 2025. GuruFocus rates XSWX:IMPN with a GF Score™ of 56/100 and a GF Value™ of CHF35.34 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Implenia AG's Research & Development for the six months ended in Dec. 2025 was CHF0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0 Mil.

Implenia AG  (XSWX:IMPN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Implenia AG Research & Development Related Terms

Implenia AG Research & Development Historical Data

* Premium members only.

The historical data trend for Implenia AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implenia AG Research & Development Chart

Implenia AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Implenia AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:IMPN
56GF Score
Implenia AG XSWX:IMPN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implenia AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0 Mil mean?
Implenia AG (XSWX:IMPN) has a Research & Development of CHF0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Implenia AG and its competitors.
Is Implenia AG's Research & Development too high?
Implenia AG's current Research & Development is CHF0 Mil. Overall, Implenia AG has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Implenia AG's Research & Development compare to PWR and FIX?
Implenia AG's Research & Development of CHF0 Mil can be compared against companies in the Construction industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Construction company?
A good Research & Development depends on the Construction industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Implenia AG and its competitors. Implenia AG's current Research & Development is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implenia AG stock overvalued right now?
Based on GuruFocus' analysis, Implenia AG (XSWX:IMPN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF35.34, compared to a current price of CHF71.90 — trading 103.5% above its estimated fair value. The current Research & Development is CHF0 Mil. Implenia AG's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Implenia AG (XSWX:IMPN), the current Research & Development is CHF0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Implenia AG (XSWX:IMPN) Overvalued in 2026?

Based on GuruFocus' analysis, Implenia AG stock appears to be overvalued. The current stock price of CHF71.90 is trading 103.5% above its estimated GF Value™ of CHF35.34. GuruFocus considers Implenia AG to be Significantly Overvalued.

Key valuation signals for XSWX:IMPN:

  • Research & Development: CHF0 Mil
  • GF Value™: CHF35.34 vs. price of CHF71.90 (103.5% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the XSWX:IMPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Implenia AG Business Description

Other Exchanges IMPNz:UK0QNT:UKI8T:Germany
Address Thurgauerstrasse 101A, Glattpark, Opfikon, Zurich, CHE, CH-8152
Implenia AG is a construction service company. The company operates through four business segments: Buildings, Civil engineering, and Service Solutions. The company's projects include complex new construction, modernization work on existing properties, tunnel construction, civil engineering, and others. The company generates majority of its revenue from Civil engineering segments, and more than half of its revenue is earned in Switzerland.
56GF Score

Get the complete analysis for XSWX:IMPN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF71.90
Price
CHF35.34
GF Value